Dr. Tan Min-Han, founder and CEO of Lucence, joins the podcast to discuss the importance of precision health in Singapore and the region. He shares his journey from being a medical oncologist and researcher to becoming an entrepreneur focused on noninvasive early detection of cancer through liquid biopsies. In this episode, he emphasizes the urgent need for early cancer detection, as 80% of cancer deaths are from unscreened cancers. Listen as he highlights the challenges of implementing change in healthcare systems and the importance of engaging stakeholders to address these gaps. Finally, he also discusses Lucence's expansion to the United States and China, as well as the company's mission to bridge the gap in cancer detection worldwide.

The show notes and transcripts for the episode can be found on nucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via [email protected].

00:39 Introduction

06:12 Lucence's value proposition in the cancer diagnostics market

11:59 Formation of Lucence's team and its evolution

23:06 Challenges in implementing change in healthcare systems

28:39 Key pillars of support and models for entrepreneurship advice

33:15 Difficulties for Asian healthcare services in securing US approval

36:34 Lucence's future expansion and impact in the world

40:13 Evolution of the life science ecosystem in Singapore